The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation
| Autor: | Peggy Appel, Richard T. Maziarz |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry medicine.medical_treatment Hematopoietic stem cell transplantation Cell therapy Transplantation Clinical trial surgical procedures operative Internal medicine Immune effector cell Medicine Peripheral blood stem cell harvest business Medicaid Reimbursement |
| Zdroj: | Blood and Marrow Transplant Handbook ISBN: 9783319138312 Blood and Marrow Transplant Handbook ISBN: 9781441975058 |
| DOI: | 10.1007/978-3-319-13832-9_2 |
| Popis: | Hematopoietic stem cell transplantation (HSCT) is extremely complex and expensive, requiring significant personnel, pharmaceutical, supportive, and patient/family resources. As indications for transplantation multiplied and transplant-related mortality declined, HSCT utilization expanded with a dramatic increase in the number of both autologous and allogeneic procedures performed over the past decade. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|